Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-12

FDA Approved: SIKLOS — Supplemental Application (Medunik)

View source ↗

Summary

FDA has approved a supplemental application for SIKLOS (hydroxyurea) filed by Medunik.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIKLOS (Hydroxyurea)

Snippet

SUPPL AP for SIKLOS (HYDROXYUREA)